ETERNA THERAPEUTICS INC (ERNA)       3.3  -0.01 (-0.3%)

3.3  -0.01 (-0.3%)

US1140822099 - Common Stock

Full estimates are only available for subscribed users, you can see which data is available below.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2016 2017 2018 2021
Revenue
22.779M
-9.21%		21.908M
-3.82%		24.833M
13.35%
EBITDA
N/A2.231M2.25M
0.85%		N/A
EBIT
-2.252M
66.04%		-1.135M
49.59%		703.8K
161.99%		-113.142M
-16,175.87%
Operating Margin
-9.89%-5.18%2.83%N/A
EPS
-61.20
62.50%		-13.46
78.00%		2.04
115.15%		-57.12
-2,900.00%

All data in USD


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q2 / 15 Q3 / 15 Q4 / 15 Q1 / 16 Q2 / 16 Q3 / 16 Q4 / 16 Q1 / 17 Q2 / 17 Q3 / 17 Q4 / 17 Q1 / 18 Q2 / 18 Q3 / 18 Q4 / 18 Q3 / 21 Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22
EPS-61.20-40.80-20.40-40.80-21.22
65.33%		-19.58
52.00%		-7.75
62.00%		-15.91
61.00%		-14.28
32.69%		-8.57
56.25%		-5.71
26.32%		-11.02
30.77%		-9.38
34.29%		-1.63
80.95%		6.12
207.14%		-1.63-2.55-2.86-2.65-2.24
-37.50%
Revenue5.712M6.324M6.732M6.018M5.763M
0.89%		5.651M
-10.64%		6.12M
-9.09%		5.63M
-6.45%		5.855M
1.60%		5.753M
1.80%		5.61M
-8.33%		5.467M
-2.90%		5.845M
-0.17%		6.038M
4.95%		7.069M
26.01%		N/AN/AN/A
EBITDA-1.02M306KN/A-693.6K112.2K
111.00%		61.2K
-80.00%		N/AN/AN/AN/A510K489.6K571.2K550.8K663K
30.00%		N/AN/AN/AN/AN/A
EBIT-2.632M-1.326M-520.2K-1.612M-805.8K
69.38%		-714K
46.15%		-234.6K
54.90%		-759.9K
52.85%		-724.2K
10.13%		-372.3K
47.86%		-204K
13.04%		-520.2K
31.54%		-408K
43.66%		91.8K
124.66%		673.2K
430.00%		-3.57M-6.63M-7.838M-6.779M-6.681M
-87.14%

All data in USD


EPS and Revenue Surprises


Recent Earnings VS Estimates (USD)
Period Reported Estimate Difference Surprise Q3 2022 -2.49 -2.24 -0.25-10.96% Q2 2022 -1.20 -2.65 1.4554.75% Q1 2022 -3.40 -2.86 -0.54-19.05% Q4 2021 -3.20 -2.55 -0.65-25.49% Q3 2021 -2.20 -1.63 -0.57-34.80% Q4 2018 4.40 6.12 -1.72-28.10% Q3 2018 3.20 -1.63 4.83296.08% Q2 2018 -2.00 -9.38 7.3878.69%
Recent Revenue VS Estimates (USD)
Period Reported Estimate Difference Surprise

EPS and Revenue Revisions


Next Q (1 month)Next Q (3 month)Next Year (1 month)Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A